[By NBC-1TV H. J Yook]Votem Co., Ltd., .(CEO Mun-Seok Kang, www.votem.kr) a Korean company specializing in medical equipment, is getting attention with sales and export growth of 100% annually since its founding in 2007.

The flagship product that Votem Co., Ltd. is currently producing is the patient monitoring device for human use (animal use), which are VP-1200 (V12), VP-1000 (V10), VP-700 (V7), VO-100 (V1), VC-2000 (Central monitoring system), etc. The patient monitoring device is a device to notify through the monitor as measuring biological signals of patients, such as body temperature, heart rate, blood pressure, electrocardiogram, etc.

The main functions are ECG module to monitor the heart rate and cardiac status of patients, Spo2 module to measure the concentration of oxygen that is saturated in the blood, NIBP module to measure the blood pressure, etc.

Besides, it also has a variety of functions such as Temp that can measure the temperature of the body, IBP that connects the sensor directly to the vessel at the time of surgery in order to know the blood pressure, ICO that can measure the heart rate, ETOC2 that measures the carbon dioxide of the last part of the breathing, etc.

In addition to these great features of the product, the company was able to enjoy remarkable growth of more than 2.7 billion won last year in the overseas patient monitoring device market through its special A/S and service upgrade.

Touching the button several times upon inserting the SD card in the back of the product in a state that does not disassemble the product modules will allow you to get A/S and upgrade. Thus, the company could significantly reduce customer complaints and the F-cost since it was not necessary to disassemble the product so that the product could be recovered during the A/S period while renting replacements.

In addition, the company plans to embark on the overseas markets including Brazil, Russia, Saudi Arabia, Turkey, Egypt, the United States, Japan and China as showcasing the modern and three-dimensional design.

“We are developing a patient monitoring system for animal in order to expand the market,” Moon Seok Kang, CEO of Votem Co., Ltd., said. “We expect the additional sales of 5 billion won in three years as we have growth rates of more than 10% per year in just the U.S. market.”